TGFB1 and pancreatic neoplasm: MCs activated CAFs and TGF-β signal pathway to increase the resistance to Gemcitabine/Nabpaclitaxel and promote tumor invasion in pancreatic cancer via PAR-2, ERK1/2 and Akt activation (84).